スソクトコグアルファ (遺伝子組換え) (JAN);
Susoctocog alfa (INN);
Susoctocog alfa (genetical recombination) (JAN)

AIRRYYLGAV ELSWDYRQSE LLRELHVDTR FPATAPGALP LGPSVLYKKT VFVEFTDQLF
SVARPRPPWM GLLGPTIQAE VYDTVVVTLK NMASHPVSLH AVGVSFWKSS EGAEYEDHTS
QREKEDDKVL PGKSQTYVWQ VLKENGPTAS DPPCLTYSYL SHVDLVKDLN SGLIGALLVC
REGSLTRERT QNLHEFVLLF AVFDEGKSWH SARNDSWTRA MDPAPARAQP AMHTVNGYVN
RSLPGLIGCH KKSVYWHVIG MGTSPEVHSI FLEGHTFLVR HHRQASLEIS PLTFLTAQTF
LMDLGQFLLF CHISSHHHGG MEAHVRVESC AEEPQLRRKA DEEEDYDDNL YDSDMDVVRL
DGDDVSPFIQ IRSVAKKHPK TWVHYISAEE EDWDYAPAVP SPSDRSYKSL YLNSGPQRIG
RKYKKARFVA YTDVTFKTRK AIPYESGILG PLLYGEVGDT LLIIFKNKAS RPYNIYPHGI
TDVSALHPGR LLKGWKHLKD MPILPGETFK YKWTVTVEDG PTKSDPRCLT RYYSSSINLE
KDLASGLIGP LLICYKESVD QRGNQMMSDK RNVILFSVFD ENQSWYLAEN IQRFLPNPDG
LQPQDPEFQA SNIMHSINGY VFDSLQLSVC LHEVAYWYIL SVGAQTDFLS VFFSGYTFKH
KMVYEDTLTL FPFSGETVFM SMENPGLWVL GCHNSDLRNR GMTALLKVYS CDRDIGDYYD
NTYEDIPGFL LSGKNVIEPR SFAQNSRPPS ASAPKPPVLR RHQRDISLPT FQPEEDKMDY
DDIFSTETKG EDFDIYGEDE NQDPRSFQKR TRHYFIAAVE QLWDYGMSES PRALRNRAQN
GEVPRFKKVV FREFADGSFT QPSYRGELNK HLGLLGPYIR AEVEDNIMVT FKNQASRPYS
FYSSLISYPD DQEQGAEPRH NFVQPNETRT YFWKVQHHMA PTEDEFDCKA WAYFSDVDLE
KDVHSGLIGP LLICRANTLN AAHGRQVTVQ EFALFFTIFD ETKSWYFTEN VERNCRAPCH
LQMEDPTLKE NYRFHAINGY VMDTLPGLVM AQNQRIRWYL LSMGSNENIH SIHFSGHVFS
VRKKEEYKMA VYNLYPGVFE TVEMLPSKVG IWRIECLIGE HLQAGMSTTF LVYSKECQAP
LGMASGRIRD FQITASGQYG QWAPKLARLH YSGSINAWST KDPHSWIKVD LLAPMIIHGI
MTQGARQKFS SLYISQFIIM YSLDGRNWQS YRGNSTGTLM VFFGNVDASG IKHNIFNPPI
VARYIRLHPT HYSIRSTLRM ELMGCDLNSC SMPLGMQNKA ISDSQITASS HLSNIFATWS
PSQARLHLQG RTNAWRPRVS SAEEWLQVDL QKTVKVTGIT TQGVKSLLSS MYVKEFLVSS
SQDGRRWTLF LQDGHTKVFQ GNQDSSTPVV NALDPPLFTR YLRIHPTSWA QHIALRLEVL
GCEAQDLY
(Disulfide bridge: 154-180, 249-330, 528-554, 630-711, 948-974, 1015-1019, 1137-1285, 1290-1442)

出血抑制

希少疾病用医薬品指定: 後天性血友病A患者における出血抑制 [DS:H00219]

DDI search